Fe3+-Induced Synchronous Formation of Composite Hydrogels for Effective Synergistic Tumor Therapy in NIR-I/II Biowindows.
Jiulong ZhaoChunhua ZhouChenyao WuHuan WuChunping ZhuChangqing YeShige WangDuo-Wu ZouPublished in: ACS applied materials & interfaces (2018)
Alginate-Ca2+ hydrogel has been used to immobilize photothermal materials as well as chemotherapy drugs at lesion sites to prevent their entry into the bloodstream. However, the alginate-Ca2+ gelation mechanism may result in hardening of the blood vessels because of Ca2+ migration to the lesion site. In this study, a unique and facile one-pot formation of chemotherapeutic (doxorubicin, DOX) and polypyrrole-containing alginate hydrogel was designed by introducing Fe3+, which can synchronously induce the polymerization of pyrrole and gelatinization of alginate, into the DOX/pyrrole/alginate solution. The formed composite hydrogel was endowed with superior photothermal conversion properties in both the NIR-I (650-950 nm) and NIR-II (1000-1700 nm) biowindows and light-to-heat conversion efficiency higher than 50%, which enabled effective tumor hyperthermia treatment. Besides, near-infrared (NIR) irradiation could be used as a remote controller to trigger the DOX-release because of the heat generation, thus achieving continuous and on-demand tumor chemotherapy. The composite polymer hydrogels exhibited favorable hemo-, cyto-, and histocompatibility, as well as simple and cost-effective preparation and good clinical prospects.
Keyphrases
- photodynamic therapy
- drug release
- drug delivery
- wound healing
- tissue engineering
- cancer therapy
- hyaluronic acid
- fluorescence imaging
- fluorescent probe
- locally advanced
- stem cells
- metal organic framework
- escherichia coli
- heat stress
- squamous cell carcinoma
- oxidative stress
- molecularly imprinted
- current status
- drug induced
- radiation induced
- gram negative
- reduced graphene oxide
- high glucose
- mesenchymal stem cells
- protein kinase
- endothelial cells
- visible light
- gold nanoparticles
- combination therapy
- bone marrow
- replacement therapy